Insight ReportRite Aid (RAD) 2Q17 RESULTS: ACQUISITION ON TRACK TO CLOSE IN 2H16 Coresight Research September 23, 2016 Executive Summary Rite Aid reported adjusted EPS of $0.03, beating the $0.02 consensus estimate and up from last year’s $0.02. Businesses that contributed to the positive results included its EnvisionRX PBM, and its strong front-end segment. There was some improvement in prescription drug costs, which was offset by challenging reimbursement rates. The company continues to believe that the announced acquisition of Rite Aid by Walgreens will close in the second half of 2016. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: NRF 2025: Retail’s Big Show: Day Two—Diving into Loyalty and Sustainability with Sephora, Target, Walmart and OthersRetail 2025: India Retail Predictions—Midyear Trends UpdateThe Agentic AI Playbook: Insights Presented by Deborah Weinswig at NRF 2025: Retail’s Big Show APACInnovator Profile: Lica World—Delivering Compelling AI-Created Video to Maximize ROAS
